ArticleBMC cancer2019

Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cells.

Eun Byeol Jo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.